Status:
NOT_YET_RECRUITING
Safety and Effectiveness of Antegrade Flexible Ureteroscopy-Assisted Percutaneous Nephrolithotomy for Staghorn Calculi
Lead Sponsor:
Tianjin Medical University Second Hospital
Collaborating Sponsors:
Chinese PLA General Hospital
Tianjin Medical University General Hospital
Conditions:
Urolithiasis
Renal Stones
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Objective This study aims to evaluate the safety and efficacy of antegrade flexible ureteroscopy-assisted PCNL for the treatment of staghorn calculi, compared with standard PCNL. Methods This prospec...
Detailed Description
Background Renal calculi are among the most common diseases in urology. Current treatment options include extracorporeal shock wave lithotripsy (ESWL), flexible ureteroscopic lithotripsy, and percutan...
Eligibility Criteria
Inclusion
- Staghorn calculi confirmed by non-contrast CT of the urinary system; Age ≥18 years; General condition suitable for surgical treatment; Ability to understand and voluntarily sign the informed consent form.
Exclusion
- Solitary kidney or congenital anomalies (such as horseshoe kidney or ectopic kidney); Patients with severe preoperative pyelonephritis; Patients with psychiatric disorders or unwilling to cooperate; Patients with uncontrolled diabetes or hypertension who cannot tolerate surgery; Patients with coagulation disorders; Patients deemed unsuitable for participation in this trial by the investigator.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
420 Patients enrolled
Trial Details
Trial ID
NCT07172373
Start Date
October 1 2025
End Date
April 30 2026
Last Update
September 15 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.